Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers
Status:
Unknown status
Trial end date:
2020-10-30
Target enrollment:
Participant gender:
Summary
The purpose of the current Study is to determine the safety and effectiveness of Galnobax®
plus Standard of Care versus only Standard of Care, in treating Diabetic Foot Ulcers (DFU).
In addition, Study is designed to investigate the safety of Galnobax® vehicle for
establishing non-deleterious effects of Vehicle on wound healing in the Subjects with DFU.
The study is being conducted in 350 subjects being recruited in about 30 centers in India.